Hospital Universitario Reina Sofia -ko ikertzaileekin lankidetzan egindako argitalpenak (26)

2024

  1. Characteristics of women with type 2 diabetes mellitus and heart failure in Spain. The DIABET-IC study

    Cardiology Journal, Vol. 31, Núm. 1, pp. 103-110

  2. Impact of the presence and type of cardiovascular disease on the risk of mortality in type 2 diabetic patients: The DIABET-IC trial

    Endocrinologia, Diabetes y Nutricion, Vol. 71, Núm. 7, pp. 278-289

  3. Prevalence and incidence of heart failure in type 2 diabetes patients: results from a nationwide prospective cohort—the DIABET-IC study

    Cardiovascular Diabetology, Vol. 23, Núm. 1

2023

  1. Impact of Advanced Age on the Incidence of Major Adverse Cardiovascular Events in Patients with Type 2 Diabetes Mellitus and Stable Coronary Artery Disease in a Real-World Setting in Spain

    Journal of Clinical Medicine, Vol. 12, Núm. 16

2022

  1. Assessment of medical management in Coronary Type 2 Diabetic patients with previous percutaneous coronary intervention in Spain: A retrospective analysis of electronic health records using Natural Language Processing

    PLoS ONE, Vol. 17, Núm. 2 February

  2. Evaluation of prophylaxis in primary prevention with acetylsalicylic acid in people with diabetes: A scoping review

    Semergen, Vol. 48, Núm. 4, pp. 275-292

  3. Major Adverse Cardiovascular Events in Coronary Type 2 Diabetic Patients: Identification of Associated Factors Using Electronic Health Records and Natural Language Processing

    Journal of Clinical Medicine, Vol. 11, Núm. 20

  4. SEMERGEN positioning on approaching chronic heart failure in primary care

    Semergen, Vol. 48, Núm. 2, pp. 106-123

  5. Use of rivaroxaban attenuates renal function impairment in patients with atrial fibrillation: insights of the EMIR study

    European Journal of Clinical Investigation

2021

  1. A new index to predict quality of anticoagulation control in patients on vitamin K antagonists: The DAFNE score

    Future Cardiology, Vol. 17, Núm. 4, pp. 685-692

  2. Association of the kdigo risk classification with the prevalence of heart failure in patients with type 2 diabetes

    Journal of Clinical Medicine, Vol. 10, Núm. 20

  3. Chronic coronary syndrome: Overcoming clinical practice guidelines. the role of the compass strategy

    Current Cardiology Reviews, Vol. 17, Núm. 3, pp. 364-375

  4. Continuity of care and protocols for lipid goals control after an acute coronary syndrome in Spain

    Atencion Primaria, Vol. 53, Núm. 3

  5. Control of LDL-C levels after an acute coronary syndrome in Spain. Are the available treatments adequately used?

    Revista Espanola de Cardiologia, Vol. 74, Núm. 2, pp. 194-196

  6. Recommendations to improve lipid control in primary prevention patients. A consensus document of the Spanish Society of Cardiology

    REC: CardioClinics, Vol. 56, Núm. 2, pp. 118-128

  7. Thromboembolic and bleeding events with rivaroxaban in clinical practice in Spain: Impact of inappropriate doses (the EMIR study)

    Journal of Comparative Effectiveness Research, Vol. 10, Núm. 7, pp. 583-593

  8. Update on dapagliflozin for heart failure with reduced ejection fraction

    Revista Espanola de Cardiologia Suplementos, Vol. 21, Núm. SB, pp. 1-9

2020

  1. Recommendations to improve lipid control. Consensus document of the Spanish Society of Cardiology

    Revista Espanola de Cardiologia, Vol. 73, Núm. 2, pp. 161-167

2019

  1. Lifestyle and cardiovascular risk factors in Spanish, Portuguese and Latin-American cardiologists. PREDICA survey

    REC: CardioClinics, Vol. 54, Núm. 1, pp. 17-26

  2. Selection of the best of 2018 in clinical cardiology

    REC: CardioClinics, Vol. 54, pp. 16-22